Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Evaluation of treatment response for breast cancer: are we entering the era of "biological complete remission"?

Bian L, Wang T, Liu Y, Zhang HQ, Song JJ, Zhang SH, Wu SK, Song ST, Jiang ZF.

Chin J Cancer Res. 2012 Dec;24(4):403-7. doi: 10.3978/j.issn.1000-9604.2012.11.01.

PMID:
23359646
[PubMed]
Free PMC Article
2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
3.

[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].

Ohsako T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1301-3. Japanese.

PMID:
16969029
[PubMed - indexed for MEDLINE]
4.

The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.

Danforth DN Jr, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD.

Breast Cancer Res Treat. 2002 Sep;75(2):135-46.

PMID:
12243506
[PubMed - indexed for MEDLINE]
5.

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.

Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Review.

PMID:
21276372
[PubMed - indexed for MEDLINE]
Free Article
6.

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Riegger C, Herrmann J, Nagarajah J, Hecktor J, Kuemmel S, Otterbach F, Hahn S, Bockisch A, Lauenstein T, Antoch G, Heusner TA.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6.

PMID:
22392069
[PubMed - indexed for MEDLINE]
7.

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.

J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9.

PMID:
8780629
[PubMed - indexed for MEDLINE]
Free Article
8.

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Shigematsu H, Nakamura Y, Tanaka K, Shiotani S, Koga C, Kawaguchi H, Nishimura S, Taguchi K, Nishiyama K, Ohno S.

Int J Clin Oncol. 2010 Dec;15(6):615-20. doi: 10.1007/s10147-010-0093-2. Epub 2010 May 15.

PMID:
20473628
[PubMed - indexed for MEDLINE]
9.

Response to therapy in breast cancer.

Avril N, Sassen S, Roylance R.

J Nucl Med. 2009 May;50 Suppl 1:55S-63S. doi: 10.2967/jnumed.108.057240. Epub 2009 Apr 20. Review.

PMID:
19380410
[PubMed - indexed for MEDLINE]
Free Article
10.

[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].

Zhao TT, Li JG, Li YM.

Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):206-9. Chinese.

PMID:
17649638
[PubMed - indexed for MEDLINE]
11.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

PMID:
18541009
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144
[PubMed - indexed for MEDLINE]
13.

[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].

Li D, Chen JH, Wang J, Ling R, Yao Q, Wang L.

Ai Zheng. 2007 Aug;26(8):900-4. Chinese.

PMID:
17697556
[PubMed - indexed for MEDLINE]
14.

Breast cancer staging in a single session: whole-body PET/CT mammography.

Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.

J Nucl Med. 2008 Aug;49(8):1215-22. doi: 10.2967/jnumed.108.052050. Epub 2008 Jul 16.

PMID:
18632831
[PubMed - indexed for MEDLINE]
Free Article
15.

Pathological complete response to trastuzumab and paclitaxel in a patient with inflammatory local recurrence following breast conserving surgery.

Nomura M, Inoue Y, Fujita S, Sakao J, Hirota M, Souda S, Ohshima M.

Breast Cancer. 2005;12(3):226-30.

PMID:
16110294
[PubMed - indexed for MEDLINE]
Free Article
16.

18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study.

Grassetto G, Fornasiero A, Otello D, Bonciarelli G, Rossi E, Nashimben O, Minicozzi AM, Crepaldi G, Pasini F, Facci E, Mandoliti G, Marzola MC, Al-Nahhas A, Rubello D.

Eur J Radiol. 2011 Dec;80(3):828-33. doi: 10.1016/j.ejrad.2010.04.029. Epub 2010 May 23.

PMID:
20547020
[PubMed - indexed for MEDLINE]
17.

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.

De Giorgi U, Mego M, Rohren EM, Liu P, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M, Ueno NT.

J Nucl Med. 2010 Aug;51(8):1213-8. doi: 10.2967/jnumed.110.076455. Epub 2010 Jul 21.

PMID:
20660382
[PubMed - indexed for MEDLINE]
Free Article
18.

[Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response].

Rai Y, Sagara Y, Sagara Y, Takahama T, Matsuyama Y, Ando M, Sagara Y, Ooi Y, Inoue K, Kurosumi M.

Gan To Kagaku Ryoho. 2007 Jan;34(1):65-8. Japanese.

PMID:
17220672
[PubMed - indexed for MEDLINE]
19.

The Effects of Preoperative (18)F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study.

Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS, Kang YJ, Park JS.

J Breast Cancer. 2012 Dec;15(4):441-8. doi: 10.4048/jbc.2012.15.4.441. Epub 2012 Dec 31.

PMID:
23346174
[PubMed]
Free PMC Article
20.

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.

Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN.

Leuk Lymphoma. 2000 Nov;39(5-6):543-53.

PMID:
11342337
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk